Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-02-28

FDA Approved: QUILLICHEW ER — Supplemental Application (NextWave Pharmaceuticals, Inc)

View source ↗

Summary

The FDA approved a supplemental application for QUILLICHEW ER (methylphenidate hydrochloride) by NextWave Pharmaceuticals, Inc., resulting in an updated label a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE)

Snippet

SUPPL AP for QUILLICHEW ER (METHYLPHENIDATE HYDROCHLORIDE)